Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy.

Area of Science:

• Neurology
• Epileptology
• Clinical Trials

Background:

• Open-label studies suggest antiseizure medications (ASMs) and devices may modify disease in focal treatment-resistant epilepsy (FTRE).
• Understanding trends in FTRE is crucial for evaluating treatment responses and potential disease-modifying effects.

Purpose of the Study:

• To investigate seizure frequency trends in patients with FTRE over an 18 to 36-month follow-up period.
• To assess the impact of interventions, including ASMs and devices, on seizure reduction in FTRE.

Main Methods:

• Prospective, observational, multicenter study (Human Epilepsy Project 2) involving 146 patients with FTRE.
• Data collected via electronic diaries, check-ins, and medical records, tracking seizure frequency, medication, and device use.
• Analysis focused on seizure freedom rates and frequency reductions, comparing intervention effects.

Main Results:

• Seizure frequency was reduced in 68.3% of participants during the second half of the study, with a mean modeled monthly reduction of 68.73%.
• Adding an ASM led to seizure frequency reduction in 66.7% of cases, but seizure freedom was uncommon.
• Participants using implantable devices showed similar seizure reduction trajectories compared to those without devices.

Conclusions:

• FTRE may demonstrate improvement over time, independent of specific interventions.
• While ASMs contribute to seizure reduction, they have a low probability of achieving complete seizure freedom in FTRE.
• The findings necessitate cautious interpretation of open-label studies regarding disease-modifying effects in FTRE and highlight the need for further research.